NCT02947724View on ClinicalTrials.gov

Surgicel Reduces Ovarian Endometriomas Recurrence

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Endometrioma
Interventions
DRUG

SURGICEL®

Insertion of 4 pieces of SURGICEL® inside the cyst cavity. Insertion of 4 pieces of SURGICEL® inside the remaining ovarian tissues.

Trial Locations (1)

115431

Kasr Elainy Hospital (Cairo University), Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02947724 - Surgicel Reduces Ovarian Endometriomas Recurrence | Biotech Hunter | Biotech Hunter